All News about Catalent, Inc. Common Stock





Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
August 12, 2022
Via Benzinga








Why Erytech Pharma Are Shares Moving Higher Today
April 25, 2022
Via Benzinga


From Catalent, Inc.
Via Business Wire


Via Benzinga




From Catalent, Inc.
Via Business Wire








Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.